Member Info for B2HS2L

Pierrick -

They may be referring to a historical RNS which uses a similar title:

Molecular respiratory panel ready for US market
Mon, 7th Oct 2019 07:00

RNS Number : 9023O
Novacyt S.A.
07 October 2019

Novacyt S.A.



("Novacyt", the "Company" or the "Group")



New molecular respiratory panel ready for the US market



Multiplex test identifies up to 37 respiratory pathogens



Paris, France and Camberley, UK - 7 October 2019 - Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces the succesful development of a new molecular diagnostic multiplex test for respiratory infections, which is ready for launch in North America in time for the US cold and flu season.



Novacyt's molecular business unit Primerdesign, has completed the design and development of the molecular respiratory panel based on a 384 well plate format for use by its North American business partner in their CLIA approved diagnostic testing laboratory network.

Income from Covid products in UK near term likely to be depressed.
Longer term, dependent on next variant (which will definitely be more transmissible), if not more severe.
Either way NHS at risk again of getting swamped factoring in re-infection rates.
RoW is our oyster.

EXMEX -
Re your link.
Job header:
Date Published: 03.02.2022 Sector: Diagnostics
Location: Camberley, South East, South Coast Discipline: Sales and Marketing, Engineering.

If 'Engineering' is a requirement, I would have thought Stokesley would have been mentioned.

Stokesley may be missing in error, or else 'Engineering' appears in error.

Something is not right IMO.

Is it possible that the 2 months is with a start date of next week - for 2 months, giving time to recruit permanent staff.

No start date stated.

JM2c

Ditto Kaeren.

I latched onto this:
"Adapting to remotely managing sales team and developing sales skills on TEAMS platform, as a response to COVID, whilst continuing coaching and mentoring individuals professional development"

Microsoft TEAMS platform I assume.

Ref https://www.youtube.com/watch?v=jKnV6H6wbNA

Haven't studied in depth - too much like work...

I think DA or a DA delegate may have the syllabus that Sarah is to oversee, and in implementing fresh training some old sales team leaders have had to go.

Sarah has been liking Novacyt posts for around a month.

EXMEX -

Unsure if I can make your day..

https://atamis-1928.cloudforce.com/sfc/p/#0O000000rwim/a/4J000000kEFW/0a.XEpAnsXhWLPDFwBk_JAjjG7TOqEVnG58sfxOiFmw

08.02.2022 - People with a vitamin D deficiency are more likely to have a severe or critical case of COVID-19, according to a new study.

https://www.webmd.com/lung/news/20220208/vitamin-d-deficiency-tied-to-severe-covid?ecd=wnl_cvd_020822&ctr=wnl-cvd-020822_lead_cta&mb=%2FTkqjjNVBqxYywBLvkGm90klslySW0RtIJ5f8LpEPug%3D

Next months feature article in Private Eye, -- thanks BH

Gazman -

HPW have done a deal with Liverpool based DAM Group:

https://businessmondays.co.uk/liverpool-company-selected-to-be-only-uk-partner-of-global-covid-19-health-passport-app/

Liam Spence, Director Of Partnerships at DAM Group Is liking

https://www.linkedin.com/in/liam-spence-243b19171/detail/recent-activity/ , and has a history of liking Novacyt LinkedIn posts.

This ties in with Robert quirke (HPW) tagging Novacyt on LinkedIn.

++++

HPW Partnership will see 90-minute PCR test deployed across over 100 clinics

https://www.med-technews.com/news/Covid-19-Medtech-News/partnership-will-see-90-minute-pcr-test-deployed-across-over/
+++

So the PCR tests used by DAM are DNA nudge plus:

https://www.businesswire.com/news/home/20220119005103/en/Award-Winning-DnaNudge-RT-PCR-Test-Integrates-With-Health-Passport-Worldwide-Digital-Health-Platform :

Consumer genetic testing pioneer DnaNudge has completed a systems-integration with digital health platform Health Passport Worldwide making international travel easier for passengers.

DnaNudge provides rapid point-of-care testing that delivers accurate results without the need for a lab or manual sample pre-processing.
- Note: Possible application here is cruise ships, no expertise, minimal equipment, little hazardous waste material.

Through their market-leading app, Health Passport Worldwide enables individuals who have had their test in a DAM Health clinic to receive their results directly to their mobile device.

The app hosts all Covid-19 travel documentation, such as Fit to Fly certificates.
It is used by healthcare providers in dozens of countries mainly in Europe, Africa and Mexico so passengers can use the same app to fly outbound and also for their return journey.
Unlike other medical records apps, Health Passport Worldwide is accepted for border entry everywhere in the world making travelling internationally easy for its customers.

+++

So if Novacyt wants to develop similar comms / fuctionality for Q instruments, (why wouldn't they), they are going to need the assistance of HPW.

IMO it might explain some of the hiring activity in IT-IS for software / firmware vacancies.

Thanks Sharestack/Wilson

https://www.crystaldiagnosticlabs.com/testing-locations/

5 Testing locations, - Three in California, Two in Texas.

Primerdesign FDA EUA requires the use of :
Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high complexity tests.

No locations offer opportunities for lab staff:
Opportunities: Full time, Part time, PRN Medical Assistants, Full Time/Part time Front desk Admin

So Crystal Diagnostics does the swabbing.
1 Are they sourcing Primerdesign assays from these labs or Primerdesign?
2 If from labs are the labs providing other swabbing centres with Primerdesign assays?

So my guess would be access to two labs, one in each state, with Crystal Diagnostics being the client.

However, if the labs are processing our assays, there could be other testing centres who use Primerdesign assays.

JM2c

Louis -
Do you think DA delivered a forward looking plan (even in draft form) to the executive leaders, who were the subject of todays Performance Share Awards programme laid out in the RNS?
I believe he would have had to provide them with something in order to put the 3 year task in perspective.

On 29th Jan I posted:

"Directors are not listening to shareholders reasonable requests for more communication."
"In short they are behaving as though PI's are an irritation"

Here is more pish poor behaviour:

I wrote to Mandy, stating that I had created a transcript of the David Allmond interview, and posted it on LSE BB.

I noted that it had been translated into French and posted on the Boursorama BB by a poster there.

I asked - In the spirit of improving share holder communications, -

that for any future company video's / interviews with members of the board,

a subsequent transcript both in English and in French should be provided.

To continue without a transcript, risks alienating French Shareholders, which is bad practice in any circumstance.

This is a poor way to treat French investors, I'm sure making them feel like second class citizens.

+++

Here is Mandy's response

Hi, - Thank you for your email.

Thank you for your feedback RE the transcript, which is noted, we appreciate you taking the time to post one on the LSE BB.

Kind regards,

Mandy

++++
My interpretation:

If the company agreed with me, they would have ensured an official transcript on headed paper was officially available in French, and another in English.

There is no undertaking to ensure such a translated transcript will be available after the next video.

That will leave quite a few disgruntled Frenchmen, and quite a few more French shares sold at ridiculous prices, adversely affecting the sp this week.

From RNS 29.09.2021

To function as a procedural meeting, the AGM requires a sufficient number of shareholders to constitute a quorum to ensure the AGM is validly held in accordance with French corporate law.
This threshold has not been met and, in accordance with Article 19 of Novacyt articles of association, the AGM will be rescheduled.

1 What will be the French response to this requirement for shareholders to register their share holding to allow a quorate meeting?

Mandy must already be scheduling a nervous breakdown before the next AGM.

2 Why isn't Jean-Pierre Crinelli making representation on behalf of French shareholders?

The board could not give a toss, until the next AGM.

BYP
It is likely that DA's future plans make these targets easily achievable.
Goodness, the sp is artificially low now, sentiment driven largely through no news.
By 2024 can we expect the dispute to have been done and dusted?
Can we expect TATA to be buying more than instruments?
Can we expect much needed non-covid projects to start delivering by the end of this year?
This month see's the advent of CO-PREP, - so presumably we will see PROmate assays sell faster.
How about an acquisition, - much more likely after the dispute ends.

I think the executive leadership team look at these figures and are saying to themselves, "we can do this with the plans DA has shown us."

It's inconceivable to me that DA has not discussed the next three years with the execs in greater detail yet.

HKK - heres a newer one, unsure if it is the latest.
https://www.londonstockexchange.com/companies-and-advisors/aim/advisers/rules/aim-rules-for-companies-updated-july2019.pdf

Try this HillSeeker - https://twitter.com/NewFormsResearc/status/1489280895576125451

Gazman -
1 LFT they are awaiting authorisation from CTDA - CTDA auth for UK market only. RoW good to go.
2 CO-Prep launch great news, we can sell a load more PROmate with that fluid handling device.

Thanks very much for finding the info Kilkenny, - much appreciated.

Is this the news which, when made public, has to be RNS'd because it is likely to move the share price..?

Yes Temuchin.
As this is a new scheme they had to announce it in full.

"The baseline for TSR is based on the average closing price of the Company's shares in December 2021 which was £3.54. This will then be compared to the equivalent figure in December 2024."

There isn't going to be a Dec 2024 if they don't improve the sp in Feb2022, - any time today will be just fine.

I think the LTIP was waiting for the appointment of Bryan Close.
The head of R&D gets the least shares, don't agree there.